Plaque Psoriasis Study Enrolling
Help Researchers Find a Clearer Future for Psoriasis
Explore a different direction for psoriasis.
The Latitude Atlas Study is comparing an investigational oral treatment, zasocitinib, to an approved oral treatment called deucravacitinib to see if it may provide a clearer future for people living with psoriasis.
- No placebo - all participants will receive either the approved or investigational drug
- Health insurance is not required to participate
- Reimbursement for time and travel may be available
You may qualify if you:
- Are 18 years of age or older
- Were diagnosed with plaque psoriasis at least 6 months ago
Study Sites
MyStudies Partner:
Get Notified About Upcoming Trials
Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.
The featured MyStudies are paid advertisements from our partners. Information contained in these listings is for general informational purposes only and does not constitute an endorsement, recommendation, or certification of any kind by NPF. Persons participating in trials, studies, or surveys assume responsibility for their participation and are advised to discuss the information shown with their health care provider.